Author

H. Hasan

Institutions: F. Hoffmann-La Roche AG, National Cancer Centre Singapore

Observed institutions: F. Hoffmann-La Roche AG, Genentech, National Cancer Centre Singapore

ORCID: 0009-0006-2980-3714

Observed ORCID: 0009-0006-2980-3714

OpenAlex ID: A5047438250

EP07.04-26 Real-World Biomarker Testing and Treatment Patterns Identified Using Machine Learning in Early Non-small Cell Lung Cancer

2023 · J.M. Lee, K. Schulze, et al. · Journal of Thoracic Oncology · 2

337P Demographic patterns and survival outcomes of patients with T and NK-cell lymphoma at the National Cancer Centre Singapore

2023 · X.Y. Lim, H. Hasan, et al. · Annals of Oncology

EP08.01-065 Prevalence of Non-driver Mutations and Characterization of Patients with Advanced or Metastatic Non-small Cell Lung Cancer

2022 · M. Provencio, D. Pérez Parente, et al. · Journal of Thoracic Oncology

1064P Genomic characterization of first line advanced or metastatic non-small cell lung cancer (aNSCLC) patients (pts) subgroups associated with good/bad prognosis

2022 · M. Provencio Pulla, D. Perez Parente, et al. · Annals of Oncology

Works count: 4

Citation count: 2

H-index: 1

I10-index: